LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 1466

Search options

  1. Article ; Online: Response to "Parathyroid Adenoma in a Young Girl with Type 3 von Willebrand Disease".

    Franchini, Massimo

    Seminars in thrombosis and hemostasis

    2022  Volume 48, Issue 5, Page(s) 627

    MeSH term(s) Female ; Humans ; Parathyroid Neoplasms ; von Willebrand Disease, Type 3 ; von Willebrand Diseases/complications ; von Willebrand Diseases/diagnosis ; von Willebrand Factor
    Chemical Substances von Willebrand Factor
    Language English
    Publishing date 2022-02-09
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 196901-8
    ISSN 1098-9064 ; 0094-6176
    ISSN (online) 1098-9064
    ISSN 0094-6176
    DOI 10.1055/s-0042-1742436
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Towards the identification of the correct place for convalescent plasma among COVID-19 therapies.

    Franchini, Massimo / Focosi, Daniele

    Infectious diseases (London, England)

    2024  Volume 56, Issue 6, Page(s) 421–422

    Language English
    Publishing date 2024-03-29
    Publishing country England
    Document type Editorial
    ZDB-ID 2839775-7
    ISSN 2374-4243 ; 2374-4235
    ISSN (online) 2374-4243
    ISSN 2374-4235
    DOI 10.1080/23744235.2024.2333977
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article: Hyperimmune Plasma and Immunoglobulins against COVID-19: A Narrative Review.

    Franchini, Massimo / Focosi, Daniele

    Life (Basel, Switzerland)

    2024  Volume 14, Issue 2

    Abstract: Since late 2019, the new SARS-CoV-2 virus belonging to ... ...

    Abstract Since late 2019, the new SARS-CoV-2 virus belonging to the
    Language English
    Publishing date 2024-02-01
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2662250-6
    ISSN 2075-1729
    ISSN 2075-1729
    DOI 10.3390/life14020214
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Innovative Therapies for Acquired Hemophilia A.

    Franchini, Massimo / Focosi, Daniele

    Seminars in thrombosis and hemostasis

    2024  

    Abstract: Acquired hemophilia A (AHA) is a rare autoimmune bleeding disorder which can be life-threatening. AHA is due to autoantibodies against coagulation factor VIII. Disease onset may be idiopathic (approximately half of the cases) or triggered by autoimmune ... ...

    Abstract Acquired hemophilia A (AHA) is a rare autoimmune bleeding disorder which can be life-threatening. AHA is due to autoantibodies against coagulation factor VIII. Disease onset may be idiopathic (approximately half of the cases) or triggered by autoimmune disorders, cancers, drugs, infections, or pregnancy. Besides treating the underlying disorder, specific AHA treatments include management of bleeding and inhibitor eradication. Various first-line and second-line hemostatic and immunosuppressive agents are currently available for the management of AHA. Recently, the hemostatic drug emicizumab and the immunosuppressive drug rituximab have been the object of intense research from investigators as innovative promising therapies for AHA. This narrative review will be focused on the current status of the clinical use of these two off-label therapeutic agents in AHA.
    Language English
    Publishing date 2024-02-23
    Publishing country United States
    Document type Journal Article
    ZDB-ID 196901-8
    ISSN 1098-9064 ; 0094-6176
    ISSN (online) 1098-9064
    ISSN 0094-6176
    DOI 10.1055/s-0044-1779737
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Inhibitor eradication and treatment for acquired hemophilia A.

    Franchini, Massimo / Focosi, Daniele

    Expert review of hematology

    2024  , Page(s) 1–8

    Abstract: Introduction: Acquired hemophilia A (AHA) is a rare hemorrhagic autoimmune disorder characterized by autoantibodies against coagulation factor VIII (FVIII). In approximately half of the cases AHA does not recognize any cause (idiopathic form), while in ... ...

    Abstract Introduction: Acquired hemophilia A (AHA) is a rare hemorrhagic autoimmune disorder characterized by autoantibodies against coagulation factor VIII (FVIII). In approximately half of the cases AHA does not recognize any cause (idiopathic form), while in the other cases it may be triggered by autoimmune disorders, cancers, drugs, infections, or pregnancy. Besides treating the underlying disorder, specific AHA treatment includes management of bleeding, if necessary, and inhibitor eradication.
    Areas covered: This narrative review summarizes the main epidemiological, clinical, laboratory, and therapeutic characteristics of AHA. In particular, it is focused on the current therapeutic options for the inhibitor eradication, also showing the latest findings on the innovative therapies. A literature search strategy was performed, without temporal limits, through Medline and PubMed electronic databases.
    Expert opinion: Various first-line and second-line immunosuppressive agents are currently available for the management of AHA. Among the latter, the anti-CD20 monoclonal antibody rituximab has been the object of intense research during the last years from investigators as innovative promising eradicating therapy for AHA. Preliminary data from the studies support the use of this drug as a first-line option for newly diagnosed AHA cases.
    Language English
    Publishing date 2024-05-09
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 2516804-6
    ISSN 1747-4094 ; 1747-4086
    ISSN (online) 1747-4094
    ISSN 1747-4086
    DOI 10.1080/17474086.2024.2352505
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Response to “Parathyroid Adenoma in a Young Girl with Type 3 von Willebrand Disease”

    Franchini, Massimo

    Seminars in Thrombosis and Hemostasis

    (Editorial Compilation—Part XII)

    2022  Volume 48, Issue 05, Page(s) 627–627

    Series title Editorial Compilation—Part XII
    Language English
    Publishing date 2022-02-09
    Publisher Thieme Medical Publishers, Inc.
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 196901-8
    ISSN 1098-9064 ; 0094-6176
    ISSN (online) 1098-9064
    ISSN 0094-6176
    DOI 10.1055/s-0042-1742436
    Database Thieme publisher's database

    More links

    Kategorien

  7. Article ; Online: COVID-19 convalescent plasma retains value for immunocompromised patients.

    Focosi, Daniele / Franchini, Massimo

    Leukemia

    2023  Volume 37, Issue 8, Page(s) 1762–1763

    MeSH term(s) Humans ; COVID-19 ; COVID-19 Serotherapy ; SARS-CoV-2 ; Immunocompromised Host
    Language English
    Publishing date 2023-06-22
    Publishing country England
    Document type Letter
    ZDB-ID 807030-1
    ISSN 1476-5551 ; 0887-6924
    ISSN (online) 1476-5551
    ISSN 0887-6924
    DOI 10.1038/s41375-023-01939-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Why should we use convalescent plasma for COVID-19?

    Franchini, Massimo

    European journal of internal medicine

    2020  Volume 77, Page(s) 150–151

    MeSH term(s) Betacoronavirus ; COVID-19 ; Coronavirus Infections/therapy ; Humans ; Immunization, Passive ; Pandemics ; Pneumonia, Viral/therapy ; SARS-CoV-2 ; Treatment Outcome ; Viral Load ; COVID-19 Serotherapy
    Keywords covid19
    Language English
    Publishing date 2020-05-16
    Publishing country Netherlands
    Document type Letter
    ZDB-ID 1038679-8
    ISSN 1879-0828 ; 0953-6205
    ISSN (online) 1879-0828
    ISSN 0953-6205
    DOI 10.1016/j.ejim.2020.05.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: SARS-CoV-2 infection, vaccination and acquired hemophilia: Reply.

    Franchini, Massimo / Focosi, Daniele

    Thrombosis research

    2023  Volume 230, Page(s) 152

    MeSH term(s) Humans ; COVID-19/prevention & control ; Hemophilia A ; SARS-CoV-2 ; Vaccination/adverse effects
    Language English
    Publishing date 2023-02-02
    Publishing country United States
    Document type Letter
    ZDB-ID 121852-9
    ISSN 1879-2472 ; 0049-3848
    ISSN (online) 1879-2472
    ISSN 0049-3848
    DOI 10.1016/j.thromres.2023.01.024
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Convalescent plasma regulation: A message in a bottle to the societies and regulatory authorities outside the US.

    Focosi, Daniele / Franchini, Massimo

    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

    2023  Volume 62, Issue 4, Page(s) 103715

    MeSH term(s) Humans ; COVID-19/therapy ; SARS-CoV-2 ; Plasma ; Immunization, Passive ; Antibodies, Viral
    Chemical Substances Antibodies, Viral
    Language English
    Publishing date 2023-04-27
    Publishing country England
    Document type Letter
    ZDB-ID 2046795-3
    ISSN 1878-1683 ; 1473-0502
    ISSN (online) 1878-1683
    ISSN 1473-0502
    DOI 10.1016/j.transci.2023.103715
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top